Academic projects

  1. Academic studies forthcoming:

Studies

Calls Principal investigators Titles
PREV'HOSPIT PHRC-N  Amandine GAGNEUX et Elisabeth BOTELHO – NEVER Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine administered during a systemic inflammatory response syndrome: a multicentre randomized study.

SPLEMENGO 

PHRC-N  Odile LAUNAY et Muhamed kheir TAHA Multicenter, randomized phase 2 trial, evaluating the immunogenicity and tolerance of three vaccine strategies against Meningococcus B in splenectomized patients.

FLUO

PHRC-N  Paul LOUBET et Odile Launay Vaccine attitudes and practices of medical specialists in hospitals
  1. Academic studies on going:

Studies Calls Principal Investigators Centers Titles
FLUVAC EV-3.7

Inserm

DRIVE (2019/2020) 

Odile Launay Cochin, Bichat, Montpellier, Lyon et Rennes Evaluation of the vaccine efficacy of the influenza vaccine in hospitalized adults

PNEUMOVAS

PHRC-N Benjamin TERRIER

Network centers: Annecy,ClermontFerrand, Cochin, Dijon, Lille, Nîmes, Rennes,Roche-sur-Yon and Strasbourg.

Outside network:

Angers, Hôpital Avicenne, Bordeaux, Brest, Créteil, Grenoble, HEGP, Metz, Nirot, Hôpital Tenon,Toulouse, Tours and Valencienne.

Test carried out with the IMMIDIATE network.

Multicentric trial comparing the immunogenicity and safety of two innovative pneumococcal vaccine strategies to standard vaccination in patients with ANCA-associated vasculitis receiving rituximab

CONDYVAC

PHRC-N  Sébastien Fouéré 

Centers of the Network : Annecy, Cochin, Lille, Lyon, Rennes et Saint-Etienne.

Evaluation of the efficacy of tetravalent HPV vaccine on the secondary prevention of reccurence of external a no genital warts in clinically cured patients in the first place 
SPLENEVAC 2 PHRC-N  Odile LAUNAY  et Benjamin ROSSI

14 centers are participating in the study, including 11 network centers:

Open centers:

Annecy, Besançon, Bichat Cochin, Dijon, Lille, Nantes, Rennes and St-Etienne.

Pending centers:

Clermont-Ferrand and Montpellier. 

Evaluation of the immunological persistence of revaccination with the PPS23 vaccine boosted or not by PCV 13 in  splenectomized patients
COVID-BCG PHRC Odile LAUNAY

18 centers participate, including 12 from the network

Prospective randomized trial evaluating the effectiveness of BCG vaccination in the prevention of COVID 19 via the strengthening of innate immunity in healthcare personnel

 

English